PsyPAN

Psychedelic Participant Advocacy Network - Improving participant wellbeing by building best practice across all levels of the global psychedelic sector.

[PsyPAN @PsyPANglobal]

We're proud to share this video explaining who we are, what our goals are and how we plan to achieve them, together as one. Beautifully brought to life by animator Sasha Frost and made possible by James and Eddie @psilonautica – huge thanks all! #advocacy #psychedelicsafeguarding

[Psychedelic Lived Experiences @psych_lived_exp]

We’re proud to be supported by these incredible organizations!

This summit is a grassroots initiative.

🎟️ Join us Nov 21–23 — Free & Virtual: https://t.co/NvuoVnEC3O

@OPEN_fndn @CIIS_SF @PareaScience @PsyPANglobal @TheraPsil @cdnpsychedelic @Psyched_Alpha @blossomact

[PsyPAN @PsyPANglobal]

The 2nd #HoloMind conference takes place in Warsaw and online on 15/16 November. Happy to be a conference partner again, where we will be presenting on the topic of 'What happens after a clinical trial?' Tickets at https://t.co/Sz1TGfAeMt - use code psypan20 for 20% off!

[PsyPAN @PsyPANglobal]

Today saw the official launch of the @PsychedelicarEU initiative at the European Parliament which aims to collect a million signatures from EU citizens to help make psychedelic-assisted therapies available and affordable in Europe. More info and sign here https://t.co/S6Dj8HZZyS

[PsyPAN @PsyPANglobal]

Find out more about ACER Integration and how to join here... https://t.co/1djs1vfQob

[PsyPAN @PsyPANglobal]

We were delighted to join @drrosalindwatts, founder of ACER Integration, for a recent Woodland Walk chat. ACER is a global online integration community and year-long programme to help people connect more deeply to the self, others, and nature https://t.co/TSIwXMAfhc

[PsyPAN @PsyPANglobal]

The discussion, which took place earlier this year @britishmuseum, features PsyPAN co-founder @IanRou, @LiamNadav (@KingsCollegeLon), @BeinerMurphy (@Imperial_PRG) and @TimmyJSDavis (@drugpolicyUK)

[PsyPAN @PsyPANglobal]

The full @psychglobal_ Symposium panel on the importance of facilitators and therapists in delivering psychedelic-assisted therapy is now available to watch... https://t.co/cXuq1hd8RY

[PsyPAN @PsyPANglobal]

Our friends @KingsCollegeLon are conducting a study of people's experience of psychedelic integration groups. The data will help improve understanding of people's longer-term needs, and optimise integration and harm reduction group protocols
Take part here https://t.co/OCFghJRwdL

[PsyPAN @PsyPANglobal]

Finally, tickets to @psychglobal_'s #PSYCHSymposium at @britishmuseum in London this Thursday are still available - use the code ROULLIER15 to get a 15% discount https://t.co/WwV3T8nC2L

[PsyPAN @PsyPANglobal]

PsyPAN co-founder @IanRou is proud to be joining @LiamNadav, @BeinerMurphy and @TimmyJSDavis for a panel on the importance of facilitators and therapists in delivering psychedelic-assisted therapies @psychglobal_'s #PSYCHSymposium this Thursday at 2.45pm

[PsyPAN @PsyPANglobal]

Ian and fellow former-trial participant and PsyPAN member and collaborator, Michael Bourne, will also be hosting a Meet The Participants Q&A workshop between 12 and 1pm @psychglobal_'s #PSYCHSymposium this Thursday

[PsyPAN @PsyPANglobal]

Proud to announce our Participant Collaboration Council project with @BeckleyPsytech has been awarded the Silver Standard in @OVIDHealth's Patient Partnership Index 2023! Can't wait to share the results of this collaboration, and how it'll help safeguard participants #PPI2023

[Beckley Psytech @BeckleyPsytech]

We’re proud to achieve the Silver Standard in @OVIDHealth's #PPI2023. This is an annual celebration of patient-pharmaceutical partnerships, and we’re honoured that our Patient Council project with @PsyPANglobal has been spotlighted this year!

[PsyPAN @PsyPANglobal]

Happening this Thursday (15th)! A free online panel discussion organised by @OPEN_fndn on the vital topic of aftercare following psychedelic trials. Speakers - PsyPAN co-founders Ian and Leonie and former MDMA therapy participant Pedram Dara. Details:
https://t.co/m7zyD2Y09v

[PsyPAN @PsyPANglobal]

@JulesEvans11 @clearrealityorg @ipanalysis Thanks for looping us in Jules. We haven't encountered anyone with HPPD who has taken part in a clinical trial - yet. As the number of participants increases, you would imagine that likelihood increases? We have spoken to Ed at PRF. Research in this area sounds much-needed

[PsyPAN @PsyPANglobal]

Huge respect for @charlotte2153 for being so courageous & open about living with #PTSD during the Commons debate on rescheduling psilocybin. This would enable more research into its effect on numerous health conditions

Watch: https://t.co/zFd4vP88SJ

@PAR_global_ @HeroicHeartsUK

[PsyPAN @PsyPANglobal]

Join us next Friday! Book tickets here and use the code PSYPAN50 to get a 50% discount: https://t.co/zZTw1uMjux

[wavepaths @wavepaths]

Join us next Friday where PsyPAN’s Leonie Schneider and Ian Roullier will be in conversation with Mendel Kaelen about the participant perspective in psychedelic-assisted therapy.

Book now: https://t.co/gMSOlQ3cI1

[PsyPAN @PsyPANglobal]

PsyPAN Co-founder Leonie Schneider spoke to @BBCRadio4 and @bbcworldservice about her experiences during @SmallPharma's #DMT-assisted therapy for #depression trial.

BBC World Service (from 37 mins): https://t.co/dxfsKD0Ecl

@BBCWorldatOne (from 22 mins): https://t.co/HMwqW90dD8

[PsyPAN @PsyPANglobal]

OEV Partners' Psychedelics & PTSD Part 2: MDMA event - 10th May. Speakers include: MDMA therapy expert @BenSessa, US police lieutenant and MDMA therapist Sarko Gergerian, and Met Police officer and expert by experience, Jennifer Schmidt-Petersen. Book here
https://t.co/3xvifVEiDo

[PsyPAN @PsyPANglobal]

Sign up here to receive future PsyPAN updates: https://t.co/dYsBoo6Yjk

[PsyPAN @PsyPANglobal]

Here are some highlights of the latest edition of the PsyPAN Newsletter:
The #PAR campaign to reschedule psilocybin continues with a new billboard campaign. PsyPAN co-founder Leonie Schneider spoke to the @EveningStandard https://t.co/nWtSugpkUD

[PsyPAN @PsyPANglobal]

Co-founder Ian Roullier spoke to @BBCRadio4 about PsyPAN and his personal journey for Inside Health. The programme features key figures leading the latest trials, providing a snapshot of the psychedelic-assisted therapy landscape, from the hope to the hype https://t.co/OP7QGUVlfd